Shenzhen Weiguang Biological Products Co., Ltd. (002880.SZ)
- Previous Close
28.61 - Open
27.70 - Bid 28.70 x --
- Ask 28.71 x --
- Day's Range
28.01 - 28.93 - 52 Week Range
22.05 - 42.18 - Volume
1,378,197 - Avg. Volume
1,297,822 - Market Cap (intraday)
6.511B - Beta (5Y Monthly) 0.12
- PE Ratio (TTM)
33.38 - EPS (TTM)
0.86 - Earnings Date --
- Forward Dividend & Yield 0.20 (0.70%)
- Ex-Dividend Date Oct 31, 2023
- 1y Target Est
--
Shenzhen Weiguang Biological Products Co., Ltd. primarily engages in the research, development, production, and sale of blood products in China. The company offers human albumin, intravenous human immunoglobulin (pH4), rabies immunoglobulin, human fibrinogen, coagulation factor, trace proteins, as well as a total of 9 varieties and 21 specifications. Shenzhen Weiguang Biological Products Co., Ltd. was founded in 1985 and is based in Shenzhen, China.
www.szwg.com796
Full Time Employees
December 31
Fiscal Year Ends
Sector
Recent News: 002880.SZ
Performance Overview: 002880.SZ
Trailing total returns as of 4/23/2024, which may include dividends or other distributions. Benchmark is .
YTD Return
1-Year Return
3-Year Return
5-Year Return
Compare To: 002880.SZ
Select to analyze similar companies using key performance metrics; select up to 4 stocks.
Statistics: 002880.SZ
Valuation Measures
Market Cap
6.49B
Enterprise Value
6.77B
Trailing P/E
33.12
Forward P/E
--
PEG Ratio (5yr expected)
--
Price/Sales (ttm)
6.54
Price/Book (mrq)
3.33
Enterprise Value/Revenue
6.82
Enterprise Value/EBITDA
28.11
Financial Highlights
Profitability and Income Statement
Profit Margin
19.75%
Return on Assets (ttm)
5.08%
Return on Equity (ttm)
10.53%
Revenue (ttm)
991.93M
Net Income Avi to Common (ttm)
195.91M
Diluted EPS (ttm)
0.86
Balance Sheet and Cash Flow
Total Cash (mrq)
192.33M
Total Debt/Equity (mrq)
23.78%
Levered Free Cash Flow (ttm)
-221.56M
Company Insights: 002880.SZ
002880.SZ does not have Company Insights